ArticleBMJ open respiratory research2016
Complications of indwelling pleural catheter use and their management.
Article in BMJ open respiratory research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03325192 (A Randomized, Double Blinded, Controlled Trial of a Rapid Pleurodesis Protocol After Indwelling Pleural Catheter Placement for Malignant Pleural Effusions), which is not on this map. Cited by 49 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Randomized, Double Blinded, Controlled Trial of a Rapid Pleurodesis Protocol After Indwelling Pleural Catheter Placement for Malignant Pleural Effusions
Who cites it
49 citing papers in PubMed, 1 synthesis or guideline pooled it, 118 citations in OpenAlex.
- Incidence of complications from indwelling pleural catheter for pleural effusion: A meta-analysis.Clinical and translational science · 2023Pooled it
- Trial
- Indwelling pleural catheter efficacy and safety in malignant vs. non-malignant pleural effusions: a prospective study.BMC pulmonary medicine · 2026Article
- Causative pathogens and clinical outcomes of pleural infection in patients without and with indwelling pleural catheters - a retrospective study from a Danish pleural clinic.European clinical respiratory journal · 2026Article
- Right-Sided Bilothorax With Secondary Empyema: A Rare Thoracic Manifestation.Case reports in pulmonology · 2026Article
- Taurolidine-Citrate Safety and Feasibility in Prevention of Indwelling Pleural Catheter-Associated Complications.CHEST pulmonary · 2025Article
- Clinical outcomes of caregiver-led indwelling pleural catheter care and drainage at a Singapore tertiary referral hospital.Journal of thoracic disease · 2025Article
- Impact of educational videos and user guide on indwelling pleural catheter caregiver training and unplanned healthcare encounters.BMJ open quality · 2025Article
- Use of an Indwelling Pleural Catheter in a Malignant Effusion With ConcurrentRespirology case reports · 2025Article
- A patient-centred approach to malignant pleural effusion.European clinical respiratory journal · 2025Review
- Pro: indwelling pleural catheters cause harm to patients.Breathe (Sheffield, England) · 2024Article
- Exploring the efficacy and advancements of medical pleurodesis: a comprehensive review of current research.Breathe (Sheffield, England) · 2024Review
- Article
- Article
- Indwelling tunneled pleural catheter infections and host related factors.Respiratory medicine · 2024Article
- Indwelling pleural catheter infection and colonisation: a clinical practice review.Journal of thoracic disease · 2024Review
- Malignant pleural disease.Breathe (Sheffield, England) · 2023Review
- Malignant pleural effusion diagnosis and therapy.Open life sciences · 2023Review
- Indwelling pleural catheter for malignant pleural effusion with persistent air leak.BMJ case reports · 2022Article
- Postoperative outcome after palliative treatment of malignant pleural effusion.Thoracic cancer · 2022Observational
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 3 institutions in 3 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The growing utilisation of indwelling pleural catheters (IPCs) has put forward a new era in the management of recurrent symptomatic pleural effusions. IPC use is safe compared to talc pleurodesis, though complications can occur. Pleural infection affects <5% of patients, and is usually responsive to antibiotic treatment without requiring catheter removal or surgery. Pleural loculations develop over time, limiting drainage in 10% of patients, which can be improved with intrapleural fibrinolytic therapy. Catheter tract metastasis can occur with most tumours but is more common in mesothelioma. The metastases usually respond to analgaesics and/or external radiotherapy. Long-term intermittent drainage of exudative effusions or chylothorax can potentially lead to loss of nutrients, though no data exist on any clinical impact. Fibrin clots within the catheter lumen can result in blockage. Chest pain following IPC insertion is often mild, and adjustments in analgaesics and drainage practice are usually all that are required. As clinical experience with the use of IPC accumulates, the profile and natural course of complications are increasingly described. We aim to summarise the available literature on IPC-related complications and the evidence to support specific strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.